Chronic low-grade inflammation and upregulation of pro-inflammatory cytokines (e.g., IL-6, TNF-α) in the comorbidity of hypertension and insulin resistance amplify the glomerular and interstitial inflammatory injury triggered by dysglycemia, dyslipidemia, and obesity (32). The gene discussed is IL6; the disease is metabolic syndrome.